Sanofi wants to dump Medivation's board after rejected deal


Save Story
Leer en español

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

NEW YORK (AP) — French drug company Sanofi is trying to toss the entire board at Medivation after the U.S. drugmaker rejected its $9.3 billion takeover bid.

Sanofi said Medivation has refused to discuss a deal. It named eight people on Wednesday that could replace Medivation's current board and who would be open to negotiations. Sanofi asked Medivation shareholders to approve its picks. Shareholders are scheduled to vote at Medivation's annual meeting now scheduled for June 22.

In a letter Wednesday, Medivation told its shareholders to reject Sanofi's attempted board coup. The San Francisco company said earlier this month that the offer from Sanofi — worth $52.50 per share — undervalued the company.

Sanofi's board nominees include former Arch Chemicals CEO Michael Campbell and Barbara Deptula, a former executive at Irish eye drugmaker Shire.

Shares of Medivation Inc. fell 64 cents to $61.27 in morning trading Wednesday. Shares of Sanofi rose 87 cents, or 2.2 percent, to $41.08.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent Business stories

Related topics

Business
The Associated Press

    STAY IN THE KNOW

    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast